| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |